13F Insight

Bello Akintunde Olatokumbo

CIK: 0002070709
Director
Primary company: Xilio Therapeutics, Inc. (XLO)

Bello Akintunde Olatokumbo is a corporate insider at Xilio Therapeutics, Inc. (XLO) filing SEC Form 4 transactions. 2 transactions. Source: SEC EDGAR.

Total Transactions
2
Total Buy Value
$0
Total Sell Value
$0
Net Activity
$0
Last Transaction
Jun 2026
Companies
1

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Award
Shares
5,000
Price
$7.99
Value
$40K
Type
Award
Shares
62,000
Price
-
Value
-